The effect of gluteus medius and quadratus lumborum dry needling in patients with patellofemoral pain syndrome
- Conditions
- Patellofemoral disorders.
- Registration Number
- IRCT20120411009440N20
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Women aged 18 to 45 years old with unilateral or bilateral patellofemoral pain syndrome; anterior or retropatellar knee pain during at least 2 following activities: prolonged sitting, ascending or descending stair,squatting, kneeling, jumping and running; pain on palpation of medial and lateral patellar facets and positive patellar grind test; an insidious onset of symptoms not related to trauma for the last 3 months; Kujula scores less than 85 out of 100; numeric rate scale scores ranging 3 to 10 during last week. having trigger point in the gluteus medius muscle in the affected side and quadratos lumbar muscle in the non-affected side
Other knee joint pathologies such as meniscus and ligament injuries, osteoarthritis and tendon impairments; patellar subluxations or dislocations; Sinding-Larsen disease;Osgood–Schlatter disease; pelica syndrome;ankle and knee injury; hip joint pathologies such as ligament injuries, osteoarthritis and tendon impairments; subluxations or dislocations and hip injury; referral pain from other joints including lumbar spine, hip and sacroiliac joints and spinal fractures; LBP without source of myofascial; any pain during sitting such as Coccydynia; previous knee surgery; Structural and biomechanical problems such as: Varus and Valgus knee; overweight 32< BMI
Prohibition the use of dry needles such as:metabolic diseases such as diabetes, rheumatic diseases and neuromuscular diseases; pregnancy; Respiratory and peripheral vascular disease, cancer and any malignancy; Immune deficiency; Menstruation; needle phobia; Hemorrhagic diseases and the use of anticoagulant drugs; liver and kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain threshold. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: algometry.;Pain intensity. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: Numeric Rate Scale (NRS).;Functional steping. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: Step down test.;Function. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: kujula questionnaire.;Balance. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: Y-Balance Test.
- Secondary Outcome Measures
Name Time Method